查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1447059

到 2030 年输血诊断市场预测：按产品、应用、最终用户和地区进行的全球分析

Blood Transfusion Diagnostics Market Forecasts to 2030 - Global Analysis By Product, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球输血诊断市场规模将达到 48 亿美元，预计到 2030 年将达到 85 亿美元，预测期内复合年增长率为 8.5%。

市场透过检测感染疾病、确定血型以及评估供血者和受血者之间的兼容性，在确保输血的安全性和有效性方面发挥关键作用。这些诊断有助于识别潜在的病原体，例如爱滋病毒、B型肝炎、C型肝炎和梅毒，从而降低透过输血感染的风险。此外，血型和交叉配血检查可确保捐赠者和受血者血液的相容性，并最大限度地减少输血过程中副作用的可能性。

Medscape 2022 年 3 月发表的报导报告称，美国A型血友病的盛行率为每 10 万名男性 20.6 人。根据加拿大血友病协会 (CHS) 2022 年 2 月发表的报导，患有A型血友病的加拿大人总数估计为 3,100 人。

增加捐血筛检计划

随着对公共卫生和安全标准的日益重视，旨在检测可能损害捐献血液完整性的感染疾病和其他健康状况的捐血筛检计画普及。这些筛检计画采用先进的诊断技术，例如核酸检测（NAT）、血清学和免疫检测，来识别与捐血相关的潜在风险，并将透过输血感染的可能性降至最低。

昂贵的设备和测试费用

输血诊断在很大程度上依赖专业设备和先进的检测，以确保输血所捐血的安全性和适用性。从自动化分析仪到​​试剂和消耗品，这些工具的购买和维护成本高。诊断过程的复杂性需要熟练的人员进行操作和解释，进一步增加了整体成本。然而，投资此类设备和进行测试的财务负担可能会很大，特别是对于资源匮乏地区和开发中国家的医疗机构来说，这可能会限制他们提供全面输血服务的能力。

医疗保健支出增加

随着医疗保健支出的增加，对先进医疗技术和程序（包括输血诊断）的需求也在增加。支出的增加使医疗机构能够投资尖端设备和诊断工具，以确保输血的安全性和有效性。此外，随着医疗保健预算的扩大，人们越来越关注改善患者的治疗结果和减少输血相关的风险，例如输血感染疾病和副作用。

限制获得先进技术

准确且有效率的输血诊断需要利用核酸增幅检查（NAT）、次世代定序（NGS）和自动化血液筛检系统等最尖端科技。许多地区，特别是开发中国家和偏远地区，可能缺乏基础设施、资源和训练有素的人员来在医疗机构中实施这些先进技术。因此，及时、准确地进行血液筛检和相容性测试的能力可能会受到影响，从而导致输血感染疾病和输血不相容等潜在风险。

COVID-19 的影响：

与新冠病毒相关的併发症，例如严重呼吸困难和其他需要输血支持的严重病症，增加了输血的需求。需求的激增给确保血液製品安全性和相容性的诊断服务带来了压力。同时，与疫情相关的法规、对感染疾病的恐惧以及医疗服务的中断导致捐血下降，影响了血液供应链。因此，输血诊断公司面临着维持充足存量基准、及时检测捐血血液以及提供有效诊断以确保大流行不确定性。

血红素密度计细分市场预计在预测期内规模最大

血红蛋白密度计可快速、可靠地评估血红蛋白浓度，协助筛检捐血并确保输血的安全性和有效性，因此预期血红蛋白密度计细分市场将成为最大的细分市场。透过让医疗保健专业人员快速测量血红蛋白浓度，血红蛋白密度计简化了捐血过程，降低了输血反应的风险，并改善了患者的整体治疗结果。此外，这些设备便携且易于使用，可用于各种医疗保健环境，包括偏远地区和资源有限的地区。

预计血型分析领域在预测期内复合年增长率最高。

预计血型领域在预测期内将出现最高的复合年增长率。准确的血型和交叉配血对于防止输血期间的副作用非常重要。血型技术和方法的进步，包括自动化系统和分子检测方法的引入，使医疗机构能够有效地确定血型并筛检不规则抗体。这显着降低了输血反应的风险并改善了患者的治疗结果。此外，由于外科手术、创伤病例和慢性病的增加，对血液製品的需求不断增加，进一步推动了输血诊断市场的区域成长。

比最大的地区

由于可支配收入增加、医疗基础设施改善、健康意识提高和有利的报销政策，北美地区在预测期内占据最大份额。美国红十字会估计，美国每年输注 1,600 万份血液成分。此外，该地区输血感染率高和捐血意识不断增强预计将刺激市场扩张。

复合年增长率最高的地区：

随着越来越多的贫血患者需要输红血球进行治疗，预计亚太地区将长期持续成长，从而推动对输血诊断的需求。由于血友病、癌症、血小板减少性疾病和慢性肾臟病(CKD) 等血液相关疾病的盛行率不断上升，该地区对血液製品和输血的整体需求很高。

提供免费客製化：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球输血诊断市场：分产品

  • 血红素计
  • 装置
  • 电浆
  • 试剂和套件
  • 其他产品

第六章全球输血诊断市场：依应用分类

  • 疾病筛检
    • 分子疾病筛检
    • 血清学疾病筛检
  • 血型分类
  • 其他用途

第七章全球输血诊断市场：依最终使用者分类

  • 诊断实验室
  • 医院
  • 其他最终用户

第八章全球输血诊断市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • Abbott Laboratories
  • BAG Healthcare GmBH
  • Bio-Rad Laboratories, Inc
  • Danaher Corporation
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd
  • Grifols SA
  • Hologic, Inc
  • Immucor, Inc
  • Ortho Clinical Diagnostics
  • Siemens Healthcare Private Limited
Product Code: SMRC25320

According to Stratistics MRC, the Global Blood Transfusion Diagnostics Market is accounted for $4.8 billion in 2023 and is expected to reach $8.5 billion by 2030 growing at a CAGR of 8.5% during the forecast period. This market serves a critical role in ensuring the safety and efficacy of blood transfusions by detecting infectious diseases, identifying blood groups, and assessing compatibility between donors and recipients. These diagnostics help identify potential pathogens such as HIV, hepatitis B and C, and syphilis, reducing the risk of transfusion-transmitted infections. Additionally, blood typing and crossmatching tests ensure compatibility between donor and recipient blood, minimizing the likelihood of adverse reactions during transfusions.

According to an article published by Medscape on March 2022, it was reported that the prevalence of Hemophilia A is 20.6 cases per 100,000 males in the United States. According to an article published by the Canadian Hemophilia Society (CHS) in February 2022, it was reported that the total number of Canadian suffering from Hemophilia A and B is estimated to be 3,100.

Market Dynamics:

Driver:

Rise in blood donor screening programs

With an increasing emphasis on public health and safety standards, blood donor screening programs have become more widespread, aiming to detect infectious diseases and other health conditions that could compromise the integrity of donated blood. These screening programs employ advanced diagnostic technologies such as nucleic acid testing (NAT), serological testing, and immunoassays to identify potential risks associated with donated blood, thus minimizing the chances of transfusion-transmitted infections.

Restraint:

High cost of equipment and tests

Blood transfusion diagnostics rely heavily on specialized equipment and sophisticated tests to ensure the safety and compatibility of donated blood for transfusion. These tools, ranging from automated analyzers to reagents and consumables, incur substantial expenses in procurement and maintenance. The complexity of diagnostic procedures necessitates skilled personnel for operation and interpretation, further adding to the overall costs. However, for healthcare facilities, especially in resource-constrained settings or developing countries, the financial burden of investing in such equipment and conducting tests can be prohibitive, limiting their capacity to offer comprehensive blood transfusion services.

Opportunity:

Increasing healthcare expenditure

As healthcare expenditure rises, there is a corresponding increase in the demand for advanced medical technologies and procedures, including blood transfusion diagnostics. This heightened expenditure allows healthcare facilities to invest in state-of-the-art equipment and diagnostic tools for ensuring the safety and efficacy of blood transfusions. Moreover, as healthcare budgets expand, there's greater focus on improving patient outcomes and reducing the risks associated with blood transfusions, such as transfusion-transmitted infections and adverse reactions.

Threat:

Limited access to advanced technologies

Access to cutting-edge technologies such as nucleic acid amplification tests (NAT), next-generation sequencing (NGS), and automated blood screening systems is essential for accurate and efficient blood transfusion diagnostics. In many regions, especially in developing countries or remote areas, healthcare facilities may lack the infrastructure, resources, or trained personnel to adopt these advanced technologies. As a result, the ability to perform timely and precise blood screening and compatibility testing may be compromised, leading to potential risks such as transfusion-transmitted infections or incompatible blood transfusions.

Covid-19 Impact:

The demand for blood transfusions increased due to Covid-related complications, such as severe respiratory distress or other critical conditions requiring transfusion support. This surge in demand placed pressure on diagnostic services to ensure the safety and compatibility of blood products. On the other hand, pandemic-related restrictions, fear of infection, and disruptions in healthcare services led to reduced blood donations, affecting the blood supply chain. Consequently, blood transfusion diagnostic companies faced challenges in maintaining adequate inventory levels and ensuring timely testing for donated blood, thus intensifying the need for efficient diagnostic solutions and technologies to safeguard transfusion safety amidst the pandemic's uncertainties.

The hemoglobinometers segment is expected to be the largest during the forecast period

Hemoglobinometers segment is expected to be the largest during the forecast period, as it provides quick and reliable assessments of hemoglobin concentration, aiding in the screening of blood donors and ensuring the safety and efficacy of transfusions. By enabling healthcare professionals to rapidly determine hemoglobin levels, hemoglobinometers streamline the blood donation process, reducing the risk of transfusion reactions and improving overall patient outcomes. Additionally, these devices are portable and user-friendly, making them accessible in a variety of healthcare settings, including remote or resource-limited areas.

The blood grouping segment is expected to have the highest CAGR during the forecast period

Blood Grouping segment is expected to have the highest CAGR during the forecast period. Accurate blood typing and crossmatching are critical to prevent adverse reactions during transfusions. With advancements in technology and techniques for blood grouping, such as the introduction of automated systems and molecular testing methods, healthcare facilities can efficiently determine blood types and screen for irregular antibodies. This has significantly reduced the risk of transfusion reactions and improved patient outcomes. Additionally, the increasing demand for blood products due to rising surgical procedures, trauma cases, and chronic diseases has further propelled the regional growth of the Blood Transfusion Diagnostics Market.

Region with largest share:

Over the projected period, the North American area held the largest share due to rising disposable income, improved health infrastructure, rising health consciousness, and favorable reimbursement policies. The American Red Cross estimates that 16 million blood components are transfused annually in the United States. Additionally, this region's high rate of transfusion-transmitted infections and rising blood donation awareness are predicted to fuel market expansion.

Region with highest CAGR:

Due to the rising number of patients with anemia which needs red blood cell transfusion for therapy, Asia Pacific is predicted to experience sustainable growth during the extended period, which is expected to drive up demand for blood transfusion diagnostics. Blood products and entire blood transfusions are in high demand in the area due to the rising prevalence of blood-related conditions such as hemophilia, cancer, thrombocytopenia, etc., and chronic kidney disease (CKD).

Key players in the market

Some of the key players in Blood Transfusion Diagnostics market include Abbott Laboratories, BAG Healthcare GmBH, Bio-Rad Laboratories, Inc, Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Grifols S.A., Hologic, Inc, Immucor, Inc, Ortho Clinical Diagnostics and Siemens Healthcare Private Limited.

Key Developments:

In February 2023, MedGenome Labs launched FSHD1 genetic screening test to assess the genetic changes in patients at early stages to facilitate better treatment options. Various government initiatives and approvals are also encouraging players to enter the market.

In November 2022, Werfen entered into an agreement with TPG to acquire Immucor, Inc. Immucor, Inc., is a global company with a wide range of portfolio in transfusion diagnostics products. This will help the company to widen its product range by including the specialized diagnostics solution of Immucor, Inc.

Products Covered:

  • Hemoglobinometers
  • Instruments
  • Plasma
  • Reagents & kits
  • Other Products

Applications Covered:

  • Disease Screening
  • Blood Grouping
  • Other Applications

End Users Covered:

  • Diagnostic Laboratories
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Blood Transfusion Diagnostics Market, By Product

  • 5.1 Introduction
  • 5.2 Hemoglobinometers
  • 5.3 Instruments
  • 5.4 Plasma
  • 5.5 Reagents & kits
  • 5.6 Other Products

6 Global Blood Transfusion Diagnostics Market, By Application

  • 6.1 Introduction
  • 6.2 Disease Screening
    • 6.2.1 Molecular Disease Screening
    • 6.2.2 Serological Disease Screening
  • 6.3 Blood Grouping
  • 6.4 Other Applications

7 Global Blood Transfusion Diagnostics Market, By End User

  • 7.1 Introduction
  • 7.2 Diagnostic Laboratories
  • 7.3 Hospitals
  • 7.4 Other End Users

8 Global Blood Transfusion Diagnostics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories
  • 10.2 BAG Healthcare GmBH
  • 10.3 Bio-Rad Laboratories, Inc
  • 10.4 Danaher Corporation
  • 10.5 DiaSorin S.p.A.
  • 10.6 F. Hoffmann-La Roche Ltd
  • 10.7 Grifols S.A.
  • 10.8 Hologic, Inc
  • 10.9 Immucor, Inc
  • 10.10 Ortho Clinical Diagnostics
  • 10.11 Siemens Healthcare Private Limited

List of Tables

  • Table 1 Global Blood Transfusion Diagnostics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Blood Transfusion Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Blood Transfusion Diagnostics Market Outlook, By Hemoglobinometers (2021-2030) ($MN)
  • Table 4 Global Blood Transfusion Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 5 Global Blood Transfusion Diagnostics Market Outlook, By Plasma (2021-2030) ($MN)
  • Table 6 Global Blood Transfusion Diagnostics Market Outlook, By Reagents & kits (2021-2030) ($MN)
  • Table 7 Global Blood Transfusion Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 8 Global Blood Transfusion Diagnostics Market Outlook, By Application (2021-2030) ($MN)
  • Table 9 Global Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2021-2030) ($MN)
  • Table 10 Global Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2021-2030) ($MN)
  • Table 11 Global Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2021-2030) ($MN)
  • Table 12 Global Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2021-2030) ($MN)
  • Table 13 Global Blood Transfusion Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 14 Global Blood Transfusion Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 15 Global Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 16 Global Blood Transfusion Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 17 Global Blood Transfusion Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 18 North America Blood Transfusion Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 19 North America Blood Transfusion Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 20 North America Blood Transfusion Diagnostics Market Outlook, By Hemoglobinometers (2021-2030) ($MN)
  • Table 21 North America Blood Transfusion Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 22 North America Blood Transfusion Diagnostics Market Outlook, By Plasma (2021-2030) ($MN)
  • Table 23 North America Blood Transfusion Diagnostics Market Outlook, By Reagents & kits (2021-2030) ($MN)
  • Table 24 North America Blood Transfusion Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 25 North America Blood Transfusion Diagnostics Market Outlook, By Application (2021-2030) ($MN)
  • Table 26 North America Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2021-2030) ($MN)
  • Table 27 North America Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2021-2030) ($MN)
  • Table 28 North America Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2021-2030) ($MN)
  • Table 29 North America Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2021-2030) ($MN)
  • Table 30 North America Blood Transfusion Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 31 North America Blood Transfusion Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 32 North America Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 33 North America Blood Transfusion Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 34 North America Blood Transfusion Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 35 Europe Blood Transfusion Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 36 Europe Blood Transfusion Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 37 Europe Blood Transfusion Diagnostics Market Outlook, By Hemoglobinometers (2021-2030) ($MN)
  • Table 38 Europe Blood Transfusion Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 39 Europe Blood Transfusion Diagnostics Market Outlook, By Plasma (2021-2030) ($MN)
  • Table 40 Europe Blood Transfusion Diagnostics Market Outlook, By Reagents & kits (2021-2030) ($MN)
  • Table 41 Europe Blood Transfusion Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 42 Europe Blood Transfusion Diagnostics Market Outlook, By Application (2021-2030) ($MN)
  • Table 43 Europe Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2021-2030) ($MN)
  • Table 44 Europe Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2021-2030) ($MN)
  • Table 45 Europe Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2021-2030) ($MN)
  • Table 46 Europe Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2021-2030) ($MN)
  • Table 47 Europe Blood Transfusion Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 48 Europe Blood Transfusion Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 49 Europe Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 50 Europe Blood Transfusion Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 51 Europe Blood Transfusion Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 52 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 53 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 54 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Hemoglobinometers (2021-2030) ($MN)
  • Table 55 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 56 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Plasma (2021-2030) ($MN)
  • Table 57 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Reagents & kits (2021-2030) ($MN)
  • Table 58 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 59 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Application (2021-2030) ($MN)
  • Table 60 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2021-2030) ($MN)
  • Table 61 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2021-2030) ($MN)
  • Table 62 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2021-2030) ($MN)
  • Table 63 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2021-2030) ($MN)
  • Table 64 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 65 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 66 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 67 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 68 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 69 South America Blood Transfusion Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 70 South America Blood Transfusion Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 71 South America Blood Transfusion Diagnostics Market Outlook, By Hemoglobinometers (2021-2030) ($MN)
  • Table 72 South America Blood Transfusion Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 73 South America Blood Transfusion Diagnostics Market Outlook, By Plasma (2021-2030) ($MN)
  • Table 74 South America Blood Transfusion Diagnostics Market Outlook, By Reagents & kits (2021-2030) ($MN)
  • Table 75 South America Blood Transfusion Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 76 South America Blood Transfusion Diagnostics Market Outlook, By Application (2021-2030) ($MN)
  • Table 77 South America Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2021-2030) ($MN)
  • Table 78 South America Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2021-2030) ($MN)
  • Table 79 South America Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2021-2030) ($MN)
  • Table 80 South America Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2021-2030) ($MN)
  • Table 81 South America Blood Transfusion Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 82 South America Blood Transfusion Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 83 South America Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 84 South America Blood Transfusion Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 85 South America Blood Transfusion Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 86 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 87 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 88 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Hemoglobinometers (2021-2030) ($MN)
  • Table 89 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 90 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Plasma (2021-2030) ($MN)
  • Table 91 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Reagents & kits (2021-2030) ($MN)
  • Table 92 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 93 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Application (2021-2030) ($MN)
  • Table 94 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2021-2030) ($MN)
  • Table 95 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2021-2030) ($MN)
  • Table 96 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2021-2030) ($MN)
  • Table 97 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2021-2030) ($MN)
  • Table 98 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 99 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 100 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 101 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 102 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)